Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure : A Cohort Study
BACKGROUND: Although frailty is strongly associated with mortality in patients with heart failure (HF), the risk of which specific cause of death is associated with being complicated with frailty is unclear. We aimed to clarify the association between multidomain frailty and the causes of death in elderly patients hospitalized with HF.
METHODS: We analyzed data from the FRAGILE-HF cohort, where patients aged 65 years and older, hospitalized with HF, were prospectively registered between 2016 and 2018 in 15 Japanese hospitals before discharge and followed up for 2 years. All patients were assessed for physical, social, and cognitive dysfunction, and categorized into 3 groups based on their number of frailty domains (FDs, 0-1, 2, and 3). Kaplan-Meier survival analysis was used to evaluate the association between the number of FDs and all-cause mortality, whereas Fine-Gray competing risk regression analysis was used for assessing the impact on cause-specific mortality.
RESULTS: We analyzed 1181 patients with HF (81 years old in median, 57.4% were male), 530 (44.9%), 437 (37.0%), and 214 (18.1%) of whom were categorized into the FD 0 to 1, FD 2, and FD 3 groups, respectively. During the 2-year follow-up, 240 deaths were observed (99 HF deaths, 34 cardiovascular deaths, and 107 noncardiovascular deaths), and an increase in the number of FD was significantly associated with mortality (Log-rank: P<0.001). The Fine-Gray competing risk analysis adjusted for age and sex showed that FDs 2 (subdistribution hazard ratio, 1.77 [95% CI, 1.11-2.81]) and 3 (2.78, [95% CI, 1.69-4.59]) groups were associated with higher incidence of noncardiovascular death but not with HF and other cardiovascular deaths.
CONCLUSIONS: Although multidomain frailty is strongly associated with mortality in older patients with HF, it is mostly attributable to noncardiovascular death and not cardiovascular death, including HF death.
REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: UMIN000023929.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Circulation. Cardiovascular quality and outcomes - (2024) vom: 26. März, Seite e010416 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ohashi, Koichi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 26.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1161/CIRCOUTCOMES.123.010416 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370191935 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370191935 | ||
| 003 | DE-627 | ||
| 005 | 20240327000818.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCOUTCOMES.123.010416 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1349.xml |
| 035 | |a (DE-627)NLM370191935 | ||
| 035 | |a (NLM)38529634 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ohashi, Koichi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure |b A Cohort Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a BACKGROUND: Although frailty is strongly associated with mortality in patients with heart failure (HF), the risk of which specific cause of death is associated with being complicated with frailty is unclear. We aimed to clarify the association between multidomain frailty and the causes of death in elderly patients hospitalized with HF | ||
| 520 | |a METHODS: We analyzed data from the FRAGILE-HF cohort, where patients aged 65 years and older, hospitalized with HF, were prospectively registered between 2016 and 2018 in 15 Japanese hospitals before discharge and followed up for 2 years. All patients were assessed for physical, social, and cognitive dysfunction, and categorized into 3 groups based on their number of frailty domains (FDs, 0-1, 2, and 3). Kaplan-Meier survival analysis was used to evaluate the association between the number of FDs and all-cause mortality, whereas Fine-Gray competing risk regression analysis was used for assessing the impact on cause-specific mortality | ||
| 520 | |a RESULTS: We analyzed 1181 patients with HF (81 years old in median, 57.4% were male), 530 (44.9%), 437 (37.0%), and 214 (18.1%) of whom were categorized into the FD 0 to 1, FD 2, and FD 3 groups, respectively. During the 2-year follow-up, 240 deaths were observed (99 HF deaths, 34 cardiovascular deaths, and 107 noncardiovascular deaths), and an increase in the number of FD was significantly associated with mortality (Log-rank: P<0.001). The Fine-Gray competing risk analysis adjusted for age and sex showed that FDs 2 (subdistribution hazard ratio, 1.77 [95% CI, 1.11-2.81]) and 3 (2.78, [95% CI, 1.69-4.59]) groups were associated with higher incidence of noncardiovascular death but not with HF and other cardiovascular deaths | ||
| 520 | |a CONCLUSIONS: Although multidomain frailty is strongly associated with mortality in older patients with HF, it is mostly attributable to noncardiovascular death and not cardiovascular death, including HF death | ||
| 520 | |a REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: UMIN000023929 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a frailty | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a phenotype | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a stroke | |
| 700 | 1 | |a Matsue, Yuya |e verfasserin |4 aut | |
| 700 | 1 | |a Maeda, Daichi |e verfasserin |4 aut | |
| 700 | 1 | |a Fujimoto, Yudai |e verfasserin |4 aut | |
| 700 | 1 | |a Kagiyama, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Sunayama, Tsutomu |e verfasserin |4 aut | |
| 700 | 1 | |a Dotare, Taishi |e verfasserin |4 aut | |
| 700 | 1 | |a Jujo, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Kazuya |e verfasserin |4 aut | |
| 700 | 1 | |a Kamiya, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ogasahara, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Maekawa, Emi |e verfasserin |4 aut | |
| 700 | 1 | |a Konishi, Masaaki |e verfasserin |4 aut | |
| 700 | 1 | |a Kitai, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Iwata, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Wada, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Hiki, Masaru |e verfasserin |4 aut | |
| 700 | 1 | |a Kasai, Takatoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Nagamatsu, Hirofumi |e verfasserin |4 aut | |
| 700 | 1 | |a Ozawa, Tetsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Izawa, Katsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Shuhei |e verfasserin |4 aut | |
| 700 | 1 | |a Aizawa, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Wakaume, Kazuki |e verfasserin |4 aut | |
| 700 | 1 | |a Oka, Kazuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Momomura, Shin-Ichi |e verfasserin |4 aut | |
| 700 | 1 | |a Minamino, Tohru |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation. Cardiovascular quality and outcomes |d 2008 |g (2024) vom: 26. März, Seite e010416 |w (DE-627)NLM193957256 |x 1941-7705 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:26 |g month:03 |g pages:e010416 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCOUTCOMES.123.010416 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 26 |c 03 |h e010416 | ||